Abstract Aim: The isolated, retrogradely perfused heart (modified Langendorff model) is a widely used method in experimental heart research. The presence of an intraventricular balloon is necessary to get functional measurements. We have previously shown that the balloon induces phosphorylation of some suggested cardioprotective mitogen-activated protein kinases (MAPK): P38-MAPK, ERK 1/2 and JNK. We hypothesized that the balloon could influence cardioprotection, protect against ischaemia reperfusion injury and interfere with coronary flow. Methods and Results: Isolated mouse hearts were perfused for 5, 10, 20, 40 and 60 min with a balloon in the left ventricle. We found a wavelike phosphorylation of all MAPK while AKT displayed a gradual dephosphorylation when compared to non-perfused hearts. Hearts were subjected to 20 min of stabilization with or without the balloon, followed by 35 min of ischaemia and 120 min of reperfusion. Although the MAPK were phosphorylated, the infarcts were larger in the balloon group. When the balloon was present during the entire protocol, compared to removal at the end of ischaemia, the infarct size was also larger, especially in the endocardial layer. The balloon reduced post-ischaemic endocardial coronary flow, despite a higher average flow, indicating a hyperperfused epicard. Blocking the balloon-induced ERK 1/2 phosphorylation during stabilization did not affect infarct size. The effect of post-conditioning was influenced by the balloon, showing reduced infarct size when the balloon was present. Conclusion: The balloon used for pressure measurements may contributes to cell death possibly by reducing endocardial coronary flow.
The mainstay therapy of acute myocardial infarction is revascularization, but it is a double-edged sword because of reperfusion injury . However, reperfusion injury may be attenuated by short episodes of ischaemia either before the prolonged, index ischaemia (Murry et al. 1986 ) (ischaemic pre-conditioning) or after the index ischaemia (post-conditioning) (Zhao et al. 2003 ). An abundance of experimental investigations have been performed to explain the mechanisms of endogenous cardioprotection (Dominguez-Rodriguez et al. 2014) . Some molecular mechanisms have been tested in patients (Kloner 2013) , but none of the techniques which experimentally increases the endogenous cell defence have so far been routinely adopted in clinical practice (Ovize et al. 2010 , Hausenloy et al. 2013 , Vander Heide & Steenbergen 2013 .
Some protein kinases have been suggested to be intracellular mediators of endogenous cardioprotection carrying the message from the cell surface to the effector organelles (Rose et al. 2010) . These include the classical mitogen-activated protein kinases (MAPK): (i) the extracellular signal-regulated protein kinase (ERK 1/2), (ii) the c-JUN NH 2 terminal kinases (JNK) and (iii) P38-MAPK (Baines & Molkentin 2005) . A central role has been attributed to ERK 1/2 which together with AKT (also known as protein kinase B) belongs to the reperfusion injury salvage kinase (RISK) pathway (Hausenloy & Yellon 2004) . ERK 1/ 2 activation has more than 100 different downstream targets (Ramos 2008) while AKT is a central regulator of cellular pathways such as growth, survival, proliferation and metabolism (Sussman et al. 2011) . Blocking AKT and ERK 1/2 abrogates the effect of preconditioning in rodent models (Hausenloy et al. 2005 ), but has inconsistent or negative results in larger animal models (Skyschally et al. 2008) .
P38-MAPK and JNK have been described as survival kinases (Hausenloy & Yellon 2006) , but the data are conflicting between detrimental and protective effect in the heart (Heusch 2015) . Common for ERK 1/2, P38-MAPK and JNK, is a definition as stress kinases. They are rapidly activated by environmental and internal factors, and many of their targets are to adjust the cells machinery to counteract stress (Coulthard et al. 2009 , Rose et al., 2010 .
Isolated, perfused heart is an extensively used model in experimental cardiac research, including investigations on endogenous cardioprotection (Langendorff 1895 , Bell et al. 2011 . We have recently shown that Langendorff perfusion of isolated rat and mouse hearts activated MAPK and downregulated AKT, disturbing the status quo of possible cardioprotective pathways (Stenslokken et al. 2009) . A significant part of the effect appeared to be caused by the balloon inserted in the left ventricle to measure intraventricular pressures. Activation of the MAPK was pronounced, and we speculate that the mode of perfusion may interfere with the results and interpretation of findings when pre-and post-conditionings are studied in isolated perfused hearts. We therefore hypothesized that the balloon-induced phosphorylation would condition the heart and reduce infarct size. Moreover, we examined whether the balloon interfered with coronary flow, resolved the time course of kinase phosphorylation/dephosphorylation during perfusion with an intraventricular balloon and investigated whether blocking balloon-induced ERK phosphorylation would interfere with infarct size. Finally, we wanted to investigate whether the presence of an intraventricular balloon would affect the outcome of post-conditioning.
Materials and methods
The experiments were approved and performed in adherence with the Norwegian Animal Health Authority, and the animals received humane care in compliance with the European Parliament on the protection of animals used for scientific purposes (2010/63/EU). All animals had conventional microbiological status. They had free access to food (RM3 from Scanbur BK AS, Nittedal, Norway) and water and were kept at a 12-h light/12-h darkness cycle in rooms where the temperature was set to 23°C and humidity to 55-60%. All animals were acclimatized for at least 7 days before experiments.
Langendorff perfusion
Unless otherwise stated, all chemicals were purchased from Sigma-Aldrich (Drammen, Norway). Male C57BL/6 mice (B&K Universal, Sollentuna, Sweden) weighing 23-28 g were anesthetized with 5% sodium pentobarbital (50 mg kg À1 ), heparinized (500 IU i.p) and killed by neck dislocation. The heart was rapidly excised and placed in ice-cold Krebs-Henseleit buffer (KHB) consisting of (mmol L À1 ): NaCl 118.5; NaHCO 3 25; KCl 4.7; KH 2 PO 4 1.2; MgSO 4 1.2; glucose 11.1; CaCl 2 1.8. The aorta was cannulated and the heart mounted on the Langendorff perfusion system (AD Instruments, Bella Vista, NSW, Australia) within 3 min. The hearts were retrogradely perfused with warm (37°C), oxygenated (95% O 2 , 5% CO 2 ) KHB at a constant pressure of 70 mmHg. The heart temperature was monitored and kept constant at 37°C during the experiment. In some groups, a fluidfilled balloon-tipped pressure catheter was inserted into the left ventricle via the left atrium to measure heart rate (HR) and ventricular pressures using the Powerlab system (AD Instruments). Intraventricular balloon for mice is not commercially available and was made in the laboratory using non-compressive ultrathin plastic (Wilder et al. 2016) . The balloon should have the following characteristics (Liao et al. 2012) : right size, highly flexible, high compliance and high linear frequency response. Left ventricular enddiastolic pressure (LVEDP) was set to 5-10 mmHg at the start of stabilization and adjusted to the same level after 10 min of stabilization. After this, LVEDP was not adjusted, and changes in LVEDP as well as left ventricular systolic pressure (LVSP) were measured during reperfusion. Left ventricular developed pressure (LVdevP = LVSPÀLVEDP) and the maximum and minimum derivatives of left ventricular pressure development (LVdp/dtmax and LVdp/dtmin) were calculated. Coronary flow (CF) was measured by timed collections of the coronary effluent. Animals with aortic cannulation time >3 min, CF >4 mL min À1 , LVSP <80 mmHg, HR <220 beats per minute at the end of stabilization or irreversible arrhythmias (asystolia or ventricular fibrillation) were excluded from the study.
Experimental groups
Series 1. Group 1.1: Isolated mouse hearts were Langendorff-perfused with an intraventricular balloon for 5, 10, 20, 40 or 60 min respectively (n = 7 in each group). Group 1.2: Mouse hearts were perfused for 30 s without the intraventricular balloon (n = 7). Group 1.3: Mouse hearts were briefly rinsed of blood by gentle shaking in KHB (n = 7).
After perfusion (or only rinsing), the hearts were rapidly frozen in liquid nitrogen for protein extraction and Western blot analysis.
Series 2. Group 2.1: Isolated mouse hearts were Langendorff-perfused with an intraventricular balloon present during stabilization for 20 min. The balloon was removed before 35 min of ischaemia and 120 min reperfusion (n = 10).
Group 2.2: Like group 2.1 except that the balloon was not inserted at any time (n = 10).
After reperfusion, the hearts were cut into four 1-mm slices along the longitudinal axis to measure infarct size.
Series 3. Group 3.1: Isolated mouse hearts were Langendorff-perfused; the protocol included 20 min of stabilization, 35 min of ischaemia and 120 min of reperfusion. An intraventricular balloon was present during the entire protocol (n = 8).
Group 3.2: Like group 3.1, but the balloon was removed after 35 min of ischaemia (n = 8).
Series 4. Group 4.1: Isolated mouse hearts were Langendorff-perfused; the protocol included 20 min of stabilization, 30 min of ischaemia and 10 min of reperfusion. An intraventricular balloon was present during the entire protocol (n = 5). After 10 min of reperfusion, the KHB was exchanged by Phthalocyanine blue (Heubach, Langelsheim, Germany) (10% in phosphate buffered saline PBS) and the heart was perfused for 15 s.
Group 4.2: Like 4.1, except the balloon was removed after 30 min of ischaemia (n = 5). These groups mimic series three except for a shorter reperfusion time.
After reperfusion, the hearts were cut into four 1-mm slices along the longitudinal axis to measure the dye penetration.
Series 5. Group 5.1: Hearts were Langendorff-perfused with KHB containing 0.02% vehicle dimethyl sulfoxide (DMSO) throughout the experiment (n = 6) and underwent 20 min of stabilization, 35 min of global ischaemia and 60 min of reperfusion. An intraventricular balloon was present during stabilization and subsequently removed.
Group 5.2: Like group 5.1, but 20 lM PD98059 (Invivogen, Toulouse, France) was added to the KHB during stabilization only (n = 8).
Series 6. Group 6.1: Isolated mouse hearts underwent 20 min of stabilization, 35 min of global ischaemia and 60 min of reperfusion. An intraventricular balloon was present during stabilization (n = 3). At start of reperfusion, the hearts underwent ischaemic postconditioning (three cycles of 10 s reperfusion/10 s of ischaemia).
Group 6.2: Like group 6.1., but no balloon was inserted (n = 5).
There are seasonal variations in tolerance to ischaemia, and because these experiments were carried out at different times, we had to vary ischaemic time in order to get the hearts to start beating (inclusion criteria).
Infarct size measurement
After reperfusion (series 2-3, 5-6), the hearts were cut into four ventricular slices of 1 mm. The slices were incubated in 1% triphenyltetrazolium chloride (TTC) for 15 min at 37°C. After incubation, the slices were gently pressed between two glass plates and photographed (Nikon Coolpix 5400, Amsterdam, the Netherlands). The infarct area was expressed as percentage of total area minus cavities and calculated blindly with Adobe Photoshop CS (Adobe, San Jose, CA, USA).
To evaluate the distribution of infarction (series 2 and 3) and perfusion efficiency (series 4), the images were obtained as described above, randomized and processed in Adobe Photoshop in the following fashion. A vector-based shape consisting of three concentric centre-aligned circles was superimposed on each slice and adjusted in four axes to divide the myocardium in two halves between the left ventricle cavity and the outer surface. The ruler tool was used to ensure that the distance between the circles delineating the inner and outer portions of the myocardium was equal along the whole perimeter. Infarct size was then calculated in the epicardial and endocardial halves and expressed as percentage of the total epicardial and endocardial layer respectively. These calculations were made by a person blinded to the experimental groups.
Phthalocyanine blue staining
Phthalocyanine blue staining has been used as an alternative to Evans Blue staining (Bohl et al. 2009 ). Phthalocyanine blue (10% in PBS) was administrated during reperfusion through a three-way valve situated directly above the heart. At the time of staining, the valve was opened for dye while stopping perfusion with KHB. After staining for 15 s, the flow was stopped and the heart was sliced similarly to the infarct size measurements. The slices were gently pressed between two glass plates and photographed (Nikon Coolpix 5400). The coloured area was expressed as percentage of total area minus cavities and calculated with Adobe Photoshop CS (Adobe) by a person blinded to the experimental groups.
Western blot
Western blot analysis was performed according to our protocol described in (Kaljusto et al. 2008) . In short: frozen heart samples were transferred to ice-cold lysis buffer and homogenized. Protein content was determined by Micro BCA protein assay kit (Pierce, Rockford, IL, USA). Proteins were loaded on a 10% sodium dodecyl sulphate-polyacrylamide gel and were electrophoretically transferred onto a hybond-P membrane (Amersham Biosciences Europe, Freiburg, Germany). The membrane was incubated overnight with primary antibodies against both phosphospecific and total forms of AKT, ERK 1/2, JNK and P38-MAPK (Cell Signaling Technology, Beverly, MA, USA). The densitometry of each band was investigated using ImageQuant software (Amersham Biosciences Europe, Freiburg, Germany). The membranes were stained with Coomassie blue (Bio-Rad Laboratories, Hercules, CA, USA) and scanned (CanonScan Lide 35; Canon Europe NV, Tokyo, Japan), and equal loading was investigated using ImageQuant on the scanned membranes. Membranes with uneven blotting were removed from the analysis.
Each gel was loaded with extracts from seven hearts per group, and this was performed twice for each comparison to allow immunoblotting with both total and phosphospecific antibodies. The arbitrary unit from the densitometry was then calculated as a ratio between the phosphorylated and non-phosphorylated form of each protein kinase for each heart. The experimental group was normalized to the mean of the control group (non-perfused).
Statistics
All the data were analysed using GRAPHPAD PRISM (version 5.04, La Jolla, CA, USA) and tested for unequal variance with a Bartlett's test and a Brown-Forsythe test. Statistical analysis of kinase phosphorylation was carried out using Kruskal-Wallis with a Dunn's posttest. For correlations between mounting the heart and phosphorylation, a Pearson test was used. Infarct size was compared using an unpaired t-test. Coronary flow was evaluated using repeated-measurements two-way ANOVA with Bonferroni post-test and an additional Student's t-test during stabilization for series 2. Differences in infarct size between epicard and endocard were assessed using ANOVA with a Bonferroni post-test. Differences between post-conditioning with or without the balloon were compared using a Welch corrected ttest. Data in text are shown as mean AE SD unless otherwise stated. In the box plots, we show median values and 5, 25, 75 and 95% percentiles.
Results

Time-dependent phosphorylation of MAPK and AKT (series 1)
Perfusion with the intraventricular balloon induced a large, rapid and sustained phosphorylation of P38-MAPK, JNK and ERK 1/2 (Fig. 1) . Both P38-MAPK and ERK 1/2 were phosphorylated after 5 min (1369 AE 188% and 412 AE 72%, respectively, compared to values from non-perfused mouse hearts (P < 0.01, Fig. 1a,b) while JNK was increased compared to non-perfused hearts after 10 min (911 AE 233%, P < 0.001, Fig. 1c) . While JNK and ERK 1/2 were still phosphorylated at 60 min of perfusion, P38-MAPK phosphorylation was not significantly increased at this time point. Although not significant, P38-MAPK phosphorylation increased to 304 AE 224% after at 30 s of perfusion. This indicates that phosphorylation of P38-MAPK is very rapidly induced, even before the insertion of the balloon into the heart. In contrast to the MAPK, AKT phosphorylation did not change rapidly, and we only observed a gradual decrease, reaching significance after 60 min (down to 47 AE 8%, P < 0.001, Fig. 1d) .
We correlated the phosphorylation at all time points for all kinases with the ischaemic time before start of perfusion (mounting time). After 5 min of perfusion, P38-MAPK phosphorylation correlated with length of ischaemic mounting time (P = 0.05, R 2 = 0.56), and a tendency was observed at 10 min (P = 0.06, R 2 = 0.52). This suggests that P38-MAPK phosphorylation to some extent may depend on the time of ischaemia during mounting the heart for perfusion. None of the other kinases demonstrated such a correlation.
Effect of balloon on infarct size and location (series 2 and 3)
To investigate whether the balloon-induced change in phosphorylation status had a pre-conditioning effect on infarct size, we inserted the balloon only during stabilization (group 2.1) vs. a control group with no balloon (group 2.2) and subjected the hearts to 35 min of ischaemia and 120 min of reperfusion. Infarct size was higher in the presence of the balloon compared to no balloon (50 AE 19% vs. 32 AE 11%, P < 0.001, Fig. 2a ). There were no differences in endocardial infarct size with or without the balloon during stabilization (data not shown). The balloon increased coronary flow during stabilization, from 1.7 AE 0.31 mL min À1 to 2.05 AE 0.31 mL min À1 (P < 0.01, Fig. 2b ).
To investigate whether the balloon might influence cardioprotection during reperfusion, we kept the balloon during the entire 20 min of stabilization, 35 min of ischaemia and 120 min of reperfusion (3.1) and compared it with removing the balloon after ischaemia (3.2). Removing the balloon at the beginning of reperfusion decreased infarct size from 54 AE 11% to 31 AE 9% (P < 0.05, Fig. 2c ). The group without the balloon during reperfusion had smaller infarct size in Changes in phosphorylation are expressed with box plots (5, 25, 75, 95% percentiles and median value) and as a ratio phospho/total normalized to the non-perfused group set to 100 (*P < 0.05, † P < 0.01, ‡ P < 0.001, n = 7 in all groups).
the endocard compared to the balloon group and also to the epicard without the balloon (Fig. 2d) . Again, average coronary flow was higher during stabilization with the balloon (2.32 AE 0.63 mL min À1 compared to 1.42 AE 0.54 mL min
À1
) but also throughout the perfusion protocol (P < 0.01, Fig. 2e) .
Effect of the balloon on myocardial perfusion (series 4)
As the infarct size in the endocard was larger in the group perfused with an intraventricular balloon during reperfusion (series 3), we wanted to investigate whether the perfusion profile was different in the two groups by perfusion with blue dye. In the presence of the balloon, there was significantly less stain in the endocard compared to the endocard without the balloon (Fig. 3 , P < 0.05). In three of the hearts, there were areas in the endocard without colour, indicating no reperfusion at all when the balloon was present (Fig. 3) . The intraventricular pressure at the end of the ischaemic period was not significantly different between the groups (38.9 AE 14.4 mmHg with balloon compared to 35.5 AE 12.4 without balloon respectively). LVEDP was 32.9 AE 18.5 in the balloon group at the time of staining, 10 min into reperfusion.
Effects of blocking ERK 1/2 phosphorylation during stabilization (series 5)
We wanted to investigate whether the balloon-induced phosphorylation of ERK 1/2 during stabilization influenced infarct size. We used a MEK1/2 inhibitor (PD98059 dissolved in DMSO). Pilot tests showed that doses above 0.02% DMSO increase ERK 1/2 phosphorylation (data not shown). We therefore chose to use 0.02%, although this was below the concentration recommended by the supplier of the inhibitor. Pilot studies showed blocking of ERK 1/2 phosphorylation with PD98059 compared to DMSO control. Perfusing the heart with PD98059 during stabilization did not influence infarct size (Fig. 4) .
Effects of balloon during post-conditioning
To study the effect of the balloon on the endogenous cardioprotection evoked by post-conditioning, we subjected mouse hearts to 20 min of stabilization, 35 min of ischaemia, three cycles of 10 s ischaemia/ 10 s reperfusion followed by 120 min of reperfusion with the balloon present in stabilization and compared to hearts where the balloon was never inserted. Mice hearts post-conditioned with the balloon during stabilization had smaller infarct size compared to post-conditioned mice hearts perfused without the balloon during stabilization (13 AE 2% compared to 28 AE 11%, respectively, P < 0.05, Fig. 5 ).
Discussion
Our main finding is that the intraventricular balloon in the Langendorff preparation increased infarct size, despite activation of suggested protective kinases. The difference was most likely caused by a ballooninduced reduction of coronary flow in the endocardial layer after the ischaemic insult. Cardiac tissue in the isolated Langendorff-perfused heart may therefore be subjected to ischaemic injury while other parts are subjected to ischaemia-reperfusion injury. The presence of the balloon also influenced cardioprotection by changing the effect of post-conditioning. To our knowledge, this is the first study to report these effects of an intraventricular balloon in the isolated, perfused heart preparation.
Kinase phosphorylation timeline
To test our hypothesis of a balloon-induced cardioprotection through protein kinases, we first investigated their time-dependent phosphorylation in the Langendorff-perfused heart set-up. As with our previous study in rats (Stenslokken et al. 2009 ), we found a pronounced waveform phosphorylation of P38-MAPK, JNK and ERK 1/2 in mice hearts. The excision, handling and perfusion also contribute to the increase in phosphorylation, but as shown in our previous study in mice, the balloon adds additional stress, and therefore more phosphorylation (Stenslokken et al. 2009 ).
In the present study, we observed a very rapid response and P38-MAPK phosphorylation tended to increase already after 30 s. After 5 min of perfusion, phosphorylation of ERK 1/2 and P38-MAPK was increased fourfold and 13-fold respectively. We found a comparably small delay in phosphorylation of JNK. A similar pattern with delayed phosphorylation of JNK has been reported with cyclic stretch in neonatal rat cardiomyocytes (de Jonge et al. 2007) , suggesting that stretch might be the trigger stimulus also in our model. Perfusion pressure, mechanical stretch, cyclic strain and shear stress are all known to activate MAPK (Komuro et al. 1996 , Clerk et al. 1998 , Seko et al. 1999 , Baba et al. 2003 , Hsieh & Nguyen 2005 , Li et al. 2005 . These stressors do not apply the same way to AKT kinase; hence, we found a steady decline in AKT phosphorylation with perfusion down to 50% of 'in vivo' levels after 60 min. In experiments with isolated hearts, it is important to avoid artefacts created by isolation stress and ensure that the heart is stabilized in the new environment. Our recommendation for isolated rat hearts included prolongation of stabilization to 40 min, when most kinases were back to baseline values (Stenslokken et al. 2009 ). The current study shows that in mice, ERK and JNK remain phosphorylated even after an hour, and only P38-MAPK is decreased to background level after 60 min. With regard to the kinases investigated in this study, there is no point prolonging stabilization beyond the usually recommended 20 min because the contractile and chronotropic functions deteriorate at a constant rate by 5-10% per hour (Bell et al. 2011) .
Handling time and kinase activation
It is impossible to start Langendorff perfusion without a short ischaemia. It is common to exclude hearts that are mounted with a delay of more than 3-4 min (Minhaz et al. 1995 , Bell et al. 2011 . Longer ischaemia may exert ischaemic pre-conditioning. In our study, we had exclusion criteria on 3 min. We found a positive correlation between early phosphorylation of P38-MAPK and length of ischaemia during preparation, similar to our previous findings in rats (Stenslokken et al. 2009 ). The range of ischaemic times in this study (between 115 and 180 s) is relatively narrow. A better correlation between phosphorylation and pre-perfusion ischaemia might be expected if the perfusion delay was more variable, but this was beyond the scope of these experiments. The general recommendation is to mount the heart as quickly as possible and exclude hearts that have been ischaemic for over three minutes.
The presence of the balloon increases infarct size
Given the central role of survival kinases in endogenous cardioprotection, we hypothesized that the balloon-induced phosphorylation of these kinases, and the RISK kinase ERK in particular, would be cardioprotective. We therefore tested mouse hearts conditioned with the balloon and compared them with the hearts without the balloon subjected to ischaemia and reperfusion. We have previously shown that mice hearts perfused for 20 min with an intraventricular balloon had increased phosphorylation of ERK 1/2, JNK and MAPKP38, compared to hearts perfused without the balloon (Stenslokken et al. 2009) .
In contrast to the hypothesis, we found that the presence of the intraventricular balloon during stabilization increased infarct size compared to hearts stabilized without the balloon, despite a massive increase in the phosphorylation of the investigated MAPK. Hence, phosphorylation of these kinases is not sufficient to salvage the myocardium. Possibly the cardiac work is increased in the presence of the balloon, because the balloon represents filling of the ventricle which the ventricle has to contract against. It has been shown that the isovolumetric contraction in the presence of an intraventricular balloon increases cardiac oxygen consumption by 35% compared to an apicobasal displacement model (Headrick et al. 2001) . The heart perfused without the balloon has performed less pre-ischaemic work; hence, the internal energy stores might be more preserved, and the hearts may tolerate the ischaemic period better. In the comparison between the isovolumetric and the apicobasal displacement, both models provided high energy charge and low cytosolic (ADP), indicating a well-oxygenated and energized myocardium (Headrick et al. 2001) . We cannot rule out a pure mechanically induced injury, although the balloon was present only during 20 min stabilization.
In series 3, the balloon was present in the left ventricle throughout the whole reperfusion period in one group, while it was removed immediately after ischaemia in the second group. Again, the group with the balloon did worse. During reperfusion, the heart undergoes contracture (Piper & Garcia-Dorado 1999) measured in the Langendorff mode as LVEDP. The difference in infarct size between these two groups was found in the endocard and may represent a balloon-induced injury. In a recent study in rats, no difference was found in infarct size between a balloon group and a non-balloon group, but interestingly, they found an increase in lactate release after removal of the balloon compared to no balloon, indicating a subendocardial hypoxia with the balloon present (Wilder et al. 2016) . Another interesting finding was a balloon-induced alteration in post-ischaemic ability for ventricular fibrillation (Wilder et al. 2016) .
The balloon changes coronary flow pattern
It is surprising that the presence of an intraventricular balloon increased average coronary flow both when present during stabilization and during reperfusion. Intuitively, the mechanical pressure on the myocardium by the balloon should reduce coronary flow. Possibly the cannula in the ascending aorta may cause insufficiency of the aortic valve so that the increased 'coronary flow' may not represent true coronary flow. To investigate whether there were local differences in coronary flow, we injected hearts with or without the balloon with Phthalocyanine blue 10 min into reperfusion. The colour stained the myocardium in three categories: dark blue, light blue and 'non-blue'. Combining areas of light blue and none blue showed the same distribution of reduced coronary flow as for hearts stained with TTC and infarct size measurement. The presence of non-blue was only seen in the endocard in the balloon group, indicating areas with no reperfusion. The reduced/no reperfusion may be due to no-reflow after ischaemia (Heusch et al. 2012) or most probably due to impaired circulation due to the hydrostatic pressure superimposed on the myocardium by the balloon. During our protocol with Phthalocyanine blue, our measured LVEDP was 33 mmHg at the time of staining, creating a delta perfusion pressure of around 35 mmHg. In severely ischaemic (60 min global ischaemia) isolated rat hearts perfused with buffer, there are very small areas with no-reflow (Ganote & Humphrey 1985) which strengthens the hypothesis that the balloon at reperfusion is the cause of the endocardial areas without perfusion.
The balloon is a necessity to obtain functional measurements in the Langendorff mode. However, it is important to recognize that the ischaemic time for the tissue is not only when perfusion is deliberately stopped, but the actual time the micro-environment is not perfused (Heusch et al. 2012) . If parts of the myocardium are not reperfused, for instance when LVEDP are higher than the perfusion pressure, the myocardium will only experience ischaemic injury and not ischaemia-reperfusion injury. LVEDP is normally adjusted during early stabilization but is kept unchanged at the end of the stabilization and used as an indicator of post-ischaemic function. We suggest that pilots should be performed on different ischaemic times, to avoid high LVEDP that will compromise endocardial reperfusion. Ischaemic injury and reperfusion injury may have different molecular responses which are then difficult to evaluate in situations with blockers or investigation of gene expression or protein analysis. These may explain some of the conflicting findings in the molecular basis of cardioprotection recently reviewed (Heusch 2015) .
ERK 1/2 phosphorylation and cardioprotection
Induced phosphorylation of ERK 1/2 coincides with increased infarct size although ERK 1/2 is suggested to be a salvage kinase important in pre-and post-conditioning (Hausenloy & Yellon 2004) . It is possible that ERK 1/2 is protective also in our hearts, but the overall effects of the isolation procedure and presence of the balloon are overriding these effects. If that was the case, blocking ERK 1/2 phosphorylation would create a bigger area of necrosis. However, we observed no effect of blocking the balloon-induced ERK phosphorylation in stabilization on infarct size.
Ischaemic pre-conditioning is known to activate ERK 1/2 before ischaemia (Mocanu et al. 2002 , Hausenloy et al. 2005 , then causing a second activation at the start of reperfusion (Hausenloy et al. 2005) . PD98059 is a widely used inhibitor of MEK1/ 2, which is upstream of ERK kinase (Hausenloy et al. 2005) and using this inhibitor during reperfusion abolishes the protective effects of both pre-and post-conditioning (Darling et al. 2005 , Hausenloy et al. 2005 . It is possible that ERK 1/2 has to be transiently upregulated as in ischaemic pre-conditioning (Hausenloy et al. 2005) , while the balloon activates it in a continuous fashion. It is also possible that ERK 1/2 phosphorylation needs to exceed a certain threshold to elicit protection, and the 66% increase we observe is not sufficient (Stenslokken et al. 2009 ).
Balloon and ischaemic post-conditioning
An interesting finding was a balloon-dependent effect on ischaemic post-conditioning. A significantly smaller infarct size was observed after post-conditioning if the balloon was present during stabilization. Owing to variability in outcomes, post-conditioned groups cannot be directly compared to non-post-conditioned groups to confirm a protective outcome. However, contrasting series 2 and series 6 suggests no post-conditioning effect in hearts lacking balloons (group 2.2 vs. 6.2). Although infarct size is reduced in post-conditioned hearts in the presence of a balloon (directly contrasting non-post-conditioned hearts), it is not possible to ascertain whether: (i) a balloon is required for expression of post-conditioning in this model or (ii) that post-conditioning arises in both models and is exaggerated by the balloon. We have no good explanation for the different effect on post-conditioning, but hearts with a balloon have a different pre-ischaemic kinase status (Stenslokken et al. 2009) . Although AKT phosphorylation is decreased with perfusion time, AKT phosphorylation is increased in the presence of the balloon (Stenslokken et al. 2009) . It is also known that AKT phosphorylation is important in ischaemic pre-and post-conditioning (Hausenloy & Yellon 2006 , Sivaraman et al. 2007 ). However, using SC79, a small molecule activator of AKT failed to reduce infarct size in isolated perfused rat hearts (Moreira et al. 2015) . If there is a threshold for the protective stimuli (Stenslokken et al. 2009 ), the combination of the balloon-induced phosphorylation of AKT and post-conditioning might reverse the increase in infarct size seen with the balloon alone. Although the physiological role for this observation is unclear, it indicates that special care must be taken when working with isolated hearts and cardiac conditioning.
Conclusions
Although the balloon is a necessity for achieving functional measurements of the isolated heart, it will influence coronary flow, infarct size and infarct location. It also contributes to the myocardial injury, possibly because the portion of myocardium around the balloon has reduced coronary flow, hence is more likely to have increased cell death. We suggest that the postischaemic LVEDP should be evaluated in pilots and ischaemic times should be chosen to ensure proper post-ischaemic reperfusion if this is studied in such experiments. The Langendorff model with an intraventricular balloon also activates a number of kinases implicated in cardioprotection. Thus, the balloon may influence cardioprotection in ways that are difficult to foresee, and this should be taken into account when designing studies and choosing models.
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